[A case of gastric cancer with multiple liver metastasis responding to combined therapy with UFT and mitomycin C].
A 66-year-old female was admitted to our hospital with the complaint of anorexia and epigastric pain. Examination of the gastrointestinal tract revealed Borrmann III type gastric carcinoma, 5 cm x 5 cm in size, in the lesser curvature of the stomach. Multiple liver metastases were detected on abdominal computed tomography. In January 1993, she underwent subtotal gastrectomy as a palliative therapy. Pathological diagnosis of the resected specimen was poorly differentiated adenocarcinoma. Two weeks after operation, administration of UFT (300-450 mg/day, orally) and mitomycin C (12 mg/three months, intravenously) was started. This chemotherapy had to be discontinued within six months because of its severe side effects, such as leukopenia and acral erythema. However, a marked reduction in the size of the metastatic liver tumors was observed on abdominal computed tomogram, and the patient is now (15 months after operation) alive without local recurrence or re-growth of liver metastatic tumors.
Tsuji
Y
Y
Dept. of Surgery, Mitsu Municipal Hospital.
Ikuta
H
H
Shibagaki
F
F
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary* / Q000601:surgery; D000284:Administration, Oral; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D005743:Gastrectomy; D006801:Humans; D007262:Infusions, Intravenous; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D016685:Mitomycin / Q000008:administration & dosage; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D005641:Tegafur; D016685:Mitomycin; D014498:Uracil